Clinical Trial Update: Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support [Phase 3]

View source ↗

Summary

Phase 3 trial update on ivabradine for cardiogenic shock requiring inotropic support in heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: The Young Investigator Group of Cardiovascular Research | Conditions: Heart Failure, Cardiogenic Shock | Phase 3 | Status: UNKNOWN